Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans

Summary A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early‐onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aging cell 2018-04, Vol.17 (2), p.n/a
Hauptverfasser: Yousefzadeh, Matthew J., Schafer, Marissa J., Noren Hooten, Nicole, Atkinson, Elizabeth J., Evans, Michele K., Baker, Darren J., Quarles, Ellen K., Robbins, Paul D., Ladiges, Warren C., LeBrasseur, Nathan K., Niedernhofer, Laura J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 2
container_start_page
container_title Aging cell
container_volume 17
creator Yousefzadeh, Matthew J.
Schafer, Marissa J.
Noren Hooten, Nicole
Atkinson, Elizabeth J.
Evans, Michele K.
Baker, Darren J.
Quarles, Ellen K.
Robbins, Paul D.
Ladiges, Warren C.
LeBrasseur, Nathan K.
Niedernhofer, Laura J.
description Summary A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early‐onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP‐1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein‐1 (MCP‐1) levels increased in an age‐dependent manner in wild‐type (WT) mice. That age‐dependent increase was accelerated in Ercc1−/Δ and Bubr1H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1−/Δ and WT mice lowered serum MCP‐1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP‐1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP‐1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.
doi_str_mv 10.1111/acel.12706
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5847863</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A705798632</galeid><sourcerecordid>A705798632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5156-2c3eec791560204bdaac2b643c966a2ab75a80dce3893508b49d164c4ed1076c3</originalsourceid><addsrcrecordid>eNp9ks-KFDEQxhtR3HX14gNIwIsIMybpdKdzEYZh_QMDXvQcqtPVM1nSyZh07zI3fQOf0Scx7ayjK2JySKXyqy_URxXFU0aXLK9XYNAtGZe0vlecMyHFQkle3z_FrDkrHqV0RSmTipYPizOuuKKM0vPi69pGMzkYrd8Sh9foEgk9GYIP5jAiMTscAoxjBDOCH8k-hhGt__7lGyOQCJB9vvvRgiMDQpoizuWtDS5srclZ2CKxngzWIAHfkT6CdeNhzu2mAXx6XDzowSV8cnteFJ_eXH5cv1tsPrx9v15tFqZiVb3gpkQ0UuWYciraDsDwthalUXUNHFpZQUM7g2Wjyoo2rVAdq4UR2DEqa1NeFK-PuvupHTCDPjfl9D7aAeJBB7D67ou3O70N17pqhGzqMgu8uBWI4fOEadSDTdl6Bx7DlDRTTcmrWlRNRp__hV6FKfrcnuaUlUxVvBG_qS041Nb3YbZ5FtUrSSup8q88U8t_UHl3mE0NHnub83cKXh4LTAwpRexPPTKq54HR88DonwOT4Wd_unJCf01IBtgRuMnfHP4jpVfry81R9Ac0P8yH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2013195284</pqid></control><display><type>article</type><title>Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Yousefzadeh, Matthew J. ; Schafer, Marissa J. ; Noren Hooten, Nicole ; Atkinson, Elizabeth J. ; Evans, Michele K. ; Baker, Darren J. ; Quarles, Ellen K. ; Robbins, Paul D. ; Ladiges, Warren C. ; LeBrasseur, Nathan K. ; Niedernhofer, Laura J.</creator><creatorcontrib>Yousefzadeh, Matthew J. ; Schafer, Marissa J. ; Noren Hooten, Nicole ; Atkinson, Elizabeth J. ; Evans, Michele K. ; Baker, Darren J. ; Quarles, Ellen K. ; Robbins, Paul D. ; Ladiges, Warren C. ; LeBrasseur, Nathan K. ; Niedernhofer, Laura J.</creatorcontrib><description>Summary A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early‐onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP‐1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein‐1 (MCP‐1) levels increased in an age‐dependent manner in wild‐type (WT) mice. That age‐dependent increase was accelerated in Ercc1−/Δ and Bubr1H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1−/Δ and WT mice lowered serum MCP‐1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP‐1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP‐1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.</description><identifier>ISSN: 1474-9718</identifier><identifier>EISSN: 1474-9726</identifier><identifier>DOI: 10.1111/acel.12706</identifier><identifier>PMID: 29290100</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Age ; Aged ; Aging ; Aging - genetics ; Animal models ; Animals ; Aortic stenosis ; biological age ; biomarkers of aging ; CCL2 ; chemokine ; Chemokine CCL2 - genetics ; Chemokine CCL2 - metabolism ; Chronic diseases ; Clinical trials ; ERCC1 protein ; Frailty - genetics ; Geriatrics ; geropathology ; Humans ; Mice ; Monocyte chemoattractant protein ; Monocyte chemoattractant protein 1 ; Monocytes ; Original ; Progeria ; Risk factors ; Stenosis</subject><ispartof>Aging cell, 2018-04, Vol.17 (2), p.n/a</ispartof><rights>2017 The Authors. published by the Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>COPYRIGHT 2017 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2018 The Anatomical Society and John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5156-2c3eec791560204bdaac2b643c966a2ab75a80dce3893508b49d164c4ed1076c3</citedby><cites>FETCH-LOGICAL-c5156-2c3eec791560204bdaac2b643c966a2ab75a80dce3893508b49d164c4ed1076c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847863/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847863/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29290100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yousefzadeh, Matthew J.</creatorcontrib><creatorcontrib>Schafer, Marissa J.</creatorcontrib><creatorcontrib>Noren Hooten, Nicole</creatorcontrib><creatorcontrib>Atkinson, Elizabeth J.</creatorcontrib><creatorcontrib>Evans, Michele K.</creatorcontrib><creatorcontrib>Baker, Darren J.</creatorcontrib><creatorcontrib>Quarles, Ellen K.</creatorcontrib><creatorcontrib>Robbins, Paul D.</creatorcontrib><creatorcontrib>Ladiges, Warren C.</creatorcontrib><creatorcontrib>LeBrasseur, Nathan K.</creatorcontrib><creatorcontrib>Niedernhofer, Laura J.</creatorcontrib><title>Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans</title><title>Aging cell</title><addtitle>Aging Cell</addtitle><description>Summary A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early‐onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP‐1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein‐1 (MCP‐1) levels increased in an age‐dependent manner in wild‐type (WT) mice. That age‐dependent increase was accelerated in Ercc1−/Δ and Bubr1H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1−/Δ and WT mice lowered serum MCP‐1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP‐1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP‐1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.</description><subject>Age</subject><subject>Aged</subject><subject>Aging</subject><subject>Aging - genetics</subject><subject>Animal models</subject><subject>Animals</subject><subject>Aortic stenosis</subject><subject>biological age</subject><subject>biomarkers of aging</subject><subject>CCL2</subject><subject>chemokine</subject><subject>Chemokine CCL2 - genetics</subject><subject>Chemokine CCL2 - metabolism</subject><subject>Chronic diseases</subject><subject>Clinical trials</subject><subject>ERCC1 protein</subject><subject>Frailty - genetics</subject><subject>Geriatrics</subject><subject>geropathology</subject><subject>Humans</subject><subject>Mice</subject><subject>Monocyte chemoattractant protein</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Monocytes</subject><subject>Original</subject><subject>Progeria</subject><subject>Risk factors</subject><subject>Stenosis</subject><issn>1474-9718</issn><issn>1474-9726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9ks-KFDEQxhtR3HX14gNIwIsIMybpdKdzEYZh_QMDXvQcqtPVM1nSyZh07zI3fQOf0Scx7ayjK2JySKXyqy_URxXFU0aXLK9XYNAtGZe0vlecMyHFQkle3z_FrDkrHqV0RSmTipYPizOuuKKM0vPi69pGMzkYrd8Sh9foEgk9GYIP5jAiMTscAoxjBDOCH8k-hhGt__7lGyOQCJB9vvvRgiMDQpoizuWtDS5srclZ2CKxngzWIAHfkT6CdeNhzu2mAXx6XDzowSV8cnteFJ_eXH5cv1tsPrx9v15tFqZiVb3gpkQ0UuWYciraDsDwthalUXUNHFpZQUM7g2Wjyoo2rVAdq4UR2DEqa1NeFK-PuvupHTCDPjfl9D7aAeJBB7D67ou3O70N17pqhGzqMgu8uBWI4fOEadSDTdl6Bx7DlDRTTcmrWlRNRp__hV6FKfrcnuaUlUxVvBG_qS041Nb3YbZ5FtUrSSup8q88U8t_UHl3mE0NHnub83cKXh4LTAwpRexPPTKq54HR88DonwOT4Wd_unJCf01IBtgRuMnfHP4jpVfry81R9Ac0P8yH</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Yousefzadeh, Matthew J.</creator><creator>Schafer, Marissa J.</creator><creator>Noren Hooten, Nicole</creator><creator>Atkinson, Elizabeth J.</creator><creator>Evans, Michele K.</creator><creator>Baker, Darren J.</creator><creator>Quarles, Ellen K.</creator><creator>Robbins, Paul D.</creator><creator>Ladiges, Warren C.</creator><creator>LeBrasseur, Nathan K.</creator><creator>Niedernhofer, Laura J.</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201804</creationdate><title>Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans</title><author>Yousefzadeh, Matthew J. ; Schafer, Marissa J. ; Noren Hooten, Nicole ; Atkinson, Elizabeth J. ; Evans, Michele K. ; Baker, Darren J. ; Quarles, Ellen K. ; Robbins, Paul D. ; Ladiges, Warren C. ; LeBrasseur, Nathan K. ; Niedernhofer, Laura J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5156-2c3eec791560204bdaac2b643c966a2ab75a80dce3893508b49d164c4ed1076c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Aged</topic><topic>Aging</topic><topic>Aging - genetics</topic><topic>Animal models</topic><topic>Animals</topic><topic>Aortic stenosis</topic><topic>biological age</topic><topic>biomarkers of aging</topic><topic>CCL2</topic><topic>chemokine</topic><topic>Chemokine CCL2 - genetics</topic><topic>Chemokine CCL2 - metabolism</topic><topic>Chronic diseases</topic><topic>Clinical trials</topic><topic>ERCC1 protein</topic><topic>Frailty - genetics</topic><topic>Geriatrics</topic><topic>geropathology</topic><topic>Humans</topic><topic>Mice</topic><topic>Monocyte chemoattractant protein</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Monocytes</topic><topic>Original</topic><topic>Progeria</topic><topic>Risk factors</topic><topic>Stenosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yousefzadeh, Matthew J.</creatorcontrib><creatorcontrib>Schafer, Marissa J.</creatorcontrib><creatorcontrib>Noren Hooten, Nicole</creatorcontrib><creatorcontrib>Atkinson, Elizabeth J.</creatorcontrib><creatorcontrib>Evans, Michele K.</creatorcontrib><creatorcontrib>Baker, Darren J.</creatorcontrib><creatorcontrib>Quarles, Ellen K.</creatorcontrib><creatorcontrib>Robbins, Paul D.</creatorcontrib><creatorcontrib>Ladiges, Warren C.</creatorcontrib><creatorcontrib>LeBrasseur, Nathan K.</creatorcontrib><creatorcontrib>Niedernhofer, Laura J.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yousefzadeh, Matthew J.</au><au>Schafer, Marissa J.</au><au>Noren Hooten, Nicole</au><au>Atkinson, Elizabeth J.</au><au>Evans, Michele K.</au><au>Baker, Darren J.</au><au>Quarles, Ellen K.</au><au>Robbins, Paul D.</au><au>Ladiges, Warren C.</au><au>LeBrasseur, Nathan K.</au><au>Niedernhofer, Laura J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans</atitle><jtitle>Aging cell</jtitle><addtitle>Aging Cell</addtitle><date>2018-04</date><risdate>2018</risdate><volume>17</volume><issue>2</issue><epage>n/a</epage><issn>1474-9718</issn><eissn>1474-9726</eissn><abstract>Summary A serum biomarker of biological versus chronological age would have significant impact on clinical care. It could be used to identify individuals at risk of early‐onset frailty or the multimorbidities associated with old age. It may also serve as a surrogate endpoint in clinical trials targeting mechanisms of aging. Here, we identified MCP‐1/CCL2, a chemokine responsible for recruiting monocytes, as a potential biomarker of biological age. Circulating monocyte chemoattractant protein‐1 (MCP‐1) levels increased in an age‐dependent manner in wild‐type (WT) mice. That age‐dependent increase was accelerated in Ercc1−/Δ and Bubr1H/H mouse models of progeria. Genetic and pharmacologic interventions that slow aging of Ercc1−/Δ and WT mice lowered serum MCP‐1 levels significantly. Finally, in elderly humans with aortic stenosis, MCP‐1 levels were significantly higher in frail individuals compared to nonfrail. These data support the conclusion that MCP‐1 can be used as a measure of mammalian biological age that is responsive to interventions that extend healthy aging.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>29290100</pmid><doi>10.1111/acel.12706</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1474-9718
ispartof Aging cell, 2018-04, Vol.17 (2), p.n/a
issn 1474-9718
1474-9726
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5847863
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Age
Aged
Aging
Aging - genetics
Animal models
Animals
Aortic stenosis
biological age
biomarkers of aging
CCL2
chemokine
Chemokine CCL2 - genetics
Chemokine CCL2 - metabolism
Chronic diseases
Clinical trials
ERCC1 protein
Frailty - genetics
Geriatrics
geropathology
Humans
Mice
Monocyte chemoattractant protein
Monocyte chemoattractant protein 1
Monocytes
Original
Progeria
Risk factors
Stenosis
title Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A24%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20levels%20of%20monocyte%20chemoattractant%20protein%E2%80%901%20as%20a%20potential%20measure%20of%20biological%20age%20in%20mice%20and%20frailty%20in%20humans&rft.jtitle=Aging%20cell&rft.au=Yousefzadeh,%20Matthew%20J.&rft.date=2018-04&rft.volume=17&rft.issue=2&rft.epage=n/a&rft.issn=1474-9718&rft.eissn=1474-9726&rft_id=info:doi/10.1111/acel.12706&rft_dat=%3Cgale_pubme%3EA705798632%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2013195284&rft_id=info:pmid/29290100&rft_galeid=A705798632&rfr_iscdi=true